A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

Authors: Hugh A. Sampson, Donald Y.M. Leung, A. Wesley Burks, Gideon Lack, Sami L. Bahna, Stacie M. Jones, Dennis A. Wong - Journal of Allergy and Clinical Immunology 2011 cited by 298